An Evening of Cocktails, Conversation, and the Future of Biomarkers

Join us at MassBio in Cambridge for an evening of cocktails, networking, and candid conversations on the future of precision medicine. Moderated by Scott Reid, PhD, this Boston stop features two interview-style discussions with Kelly Gordon, CEO of Boudicca DX, and Doug Bowman, VP of Precision Medicine at Indica Labs, exploring biomarker strategy, companion diagnostics, and the evolving role of AI in digital pathology.

No slide decks. No sales pitches. Just practical insights, audience Q&A, and meaningful conversations with peers across pharma, biotech, and diagnostics.